Hazard Information | Back Directory | [Uses]
Narlumosbart (JMT103) is an IgG4κ antibody targeting receptor activator of nuclear factor-κB ligand (RANKL)[1]. | [References]
[1] Kaplon H, Crescioli S, Chenoweth A, Visweswaraiah J, Reichert JM. Antibodies to watch in 2023. MAbs. 2023 Jan-Dec;15(1):2153410. DOI:10.1080/19420862.2022.2153410 |
|
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 |
Website: |
www.biolabreagent.com/ |
|